The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Gleevec-Global Market Insights and Sales Trends 2025
Synopsis
Imatinib is a medication used to treat cancer.
The global Gleevec market size is expected to reach US$ 595.2 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Gleevec in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling Gleevec market. 100mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 400mg segment is estimated at % CAGR for the next seven-year period.
For many patients with CML and GIST, Gleevec became a long-term treatment to manage their condition effectively. This sustained demand was driven by the need for ongoing therapy to control cancer progression.
Over time, Gleevec's efficacy in other cancers or its potential use in combination with other treatments may have led to an increase in demand for off-label or investigational uses.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gleevec, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gleevec market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gleevec market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gleevec sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gleevec covered in this report include Novartis. etc.
The global Gleevec market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Global Gleevec market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gleevec market, Segment by Type:
100mg
400mg
Global Gleevec market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Gleevec manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Gleevec in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Imatinib is a medication used to treat cancer.
The global Gleevec market size is expected to reach US$ 595.2 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Gleevec in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling Gleevec market. 100mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 400mg segment is estimated at % CAGR for the next seven-year period.
For many patients with CML and GIST, Gleevec became a long-term treatment to manage their condition effectively. This sustained demand was driven by the need for ongoing therapy to control cancer progression.
Over time, Gleevec's efficacy in other cancers or its potential use in combination with other treatments may have led to an increase in demand for off-label or investigational uses.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gleevec, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gleevec market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gleevec market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gleevec sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gleevec covered in this report include Novartis. etc.
The global Gleevec market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Global Gleevec market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gleevec market, Segment by Type:
100mg
400mg
Global Gleevec market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Gleevec manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Gleevec in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Gleevec Market Overview
1.1 Gleevec Product Overview
1.2 Gleevec Market Segment by Type
1.2.1 100mg
1.2.2 400mg
1.3 Global Gleevec Market Size by Type
1.3.1 Global Gleevec Market Size Overview by Type (2018-2029)
1.3.2 Global Gleevec Historic Market Size Review by Type (2018-2023)
1.3.3 Global Gleevec Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gleevec Sales Breakdown by Type (2018-2023)
1.4.2 Europe Gleevec Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Gleevec Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Gleevec Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Gleevec Sales Breakdown by Type (2018-2023)
2 Global Gleevec Market Competition by Company
2.1 Global Top Players by Gleevec Sales (2018-2023)
2.2 Global Top Players by Gleevec Revenue (2018-2023)
2.3 Global Top Players by Gleevec Price (2018-2023)
2.4 Global Top Manufacturers Gleevec Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gleevec Market Competitive Situation and Trends
2.5.1 Gleevec Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Gleevec Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gleevec as of 2022)
2.7 Date of Key Manufacturers Enter into Gleevec Market
2.8 Key Manufacturers Gleevec Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gleevec Status and Outlook by Region
3.1 Global Gleevec Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Gleevec Historic Market Size by Region
3.2.1 Global Gleevec Sales in Volume by Region (2018-2023)
3.2.2 Global Gleevec Sales in Value by Region (2018-2023)
3.2.3 Global Gleevec Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Gleevec Forecasted Market Size by Region
3.3.1 Global Gleevec Sales in Volume by Region (2024-2029)
3.3.2 Global Gleevec Sales in Value by Region (2024-2029)
3.3.3 Global Gleevec Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Gleevec by Application
4.1 Gleevec Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Gleevec Market Size by Application
4.2.1 Global Gleevec Market Size Overview by Application (2018-2029)
4.2.2 Global Gleevec Historic Market Size Review by Application (2018-2023)
4.2.3 Global Gleevec Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gleevec Sales Breakdown by Application (2018-2023)
4.3.2 Europe Gleevec Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Gleevec Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Gleevec Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Gleevec Sales Breakdown by Application (2018-2023)
5 North America Gleevec by Country
5.1 North America Gleevec Historic Market Size by Country
5.1.1 North America Gleevec Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Gleevec Sales in Volume by Country (2018-2023)
5.1.3 North America Gleevec Sales in Value by Country (2018-2023)
5.2 North America Gleevec Forecasted Market Size by Country
5.2.1 North America Gleevec Sales in Volume by Country (2024-2029)
5.2.2 North America Gleevec Sales in Value by Country (2024-2029)
6 Europe Gleevec by Country
6.1 Europe Gleevec Historic Market Size by Country
6.1.1 Europe Gleevec Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Gleevec Sales in Volume by Country (2018-2023)
6.1.3 Europe Gleevec Sales in Value by Country (2018-2023)
6.2 Europe Gleevec Forecasted Market Size by Country
6.2.1 Europe Gleevec Sales in Volume by Country (2024-2029)
6.2.2 Europe Gleevec Sales in Value by Country (2024-2029)
7 Asia-Pacific Gleevec by Region
7.1 Asia-Pacific Gleevec Historic Market Size by Region
7.1.1 Asia-Pacific Gleevec Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Gleevec Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Gleevec Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Gleevec Forecasted Market Size by Region
7.2.1 Asia-Pacific Gleevec Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Gleevec Sales in Value by Region (2024-2029)
8 Latin America Gleevec by Country
8.1 Latin America Gleevec Historic Market Size by Country
8.1.1 Latin America Gleevec Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Gleevec Sales in Volume by Country (2018-2023)
8.1.3 Latin America Gleevec Sales in Value by Country (2018-2023)
8.2 Latin America Gleevec Forecasted Market Size by Country
8.2.1 Latin America Gleevec Sales in Volume by Country (2024-2029)
8.2.2 Latin America Gleevec Sales in Value by Country (2024-2029)
9 Middle East and Africa Gleevec by Country
9.1 Middle East and Africa Gleevec Historic Market Size by Country
9.1.1 Middle East and Africa Gleevec Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Gleevec Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Gleevec Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Gleevec Forecasted Market Size by Country
9.2.1 Middle East and Africa Gleevec Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Gleevec Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Gleevec Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis Gleevec Products Offered
10.1.5 Novartis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gleevec Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gleevec Industrial Chain Analysis
11.4 Gleevec Market Dynamics
11.4.1 Gleevec Industry Trends
11.4.2 Gleevec Market Drivers
11.4.3 Gleevec Market Challenges
11.4.4 Gleevec Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gleevec Distributors
12.3 Gleevec Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
